Resistance to antiretroviral drugs

被引：0

作者：

Calvez, V ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, CERVI, Dept Virol, Paris, France

来源：

ANTIVIRAL THERAPY | 1998年 / 3卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

There ave many questions regarding testing for viral resistance to antiretroviral drugs and interpretation of test results. The most appropriate time for testing and the compartment from which to derive virus ave still uncertain. Both phenotypic and genotypic tests are used to measure drug susceptibility; however, interpretation of results of these assessments is not clear-cut. Furthermore, correlation of these test results with clinical outcome or pharmacological data is limited by lack of studies and other confounding factors.

引用

页码：5 / 7

页数：3

共 9 条

[1]

CALVEZ V, 1997, ANTIVIRAL THERAPY S3, V2, P107

[2] ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY [J].

DAQUILA, RT ;

JOHNSON, VA ;

WELLES, SL ;

JAPOUR, AJ ;

KURITZKES, DR ;

DEGRUTTOLA, V ;

REICHELDERFER, PS ;

COOMBS, RW ;

CRUMPACKER, CS ;

KAHN, JO ;

RICHMAN, DD .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) :401-408

[3]

DEJONG MD, 1995, 5 EUR C CLIN ASP TRE

[4] HIGH-LEVEL RESISTANCE TO ZIDOVUDINE BUT NOT TO ZALCITABINE OR DIDANOSINE IN HUMAN-IMMUNODEFICIENCY-VIRUS FROM CHILDREN RECEIVING ANTIRETROVIRAL THERAPY [J].

HUSSON, RN ;

SHIRASAKA, T ;

BUTLER, KM ;

PIZZO, PA ;

MITSUYA, H .

JOURNAL OF PEDIATRICS, 1993, 123 (01) :9-16

[5]

KATLAMA C, 1997, ANTIVIRAL THERAPY S3, V2, P105

[6] NOVEL MUTATION (V75T) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS RESISTANCE TO 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE IN CELL-CULTURE [J].

LACEY, SF ;

LARDER, BA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1428-1432

[7] GENOTYPIC AND PHENOTYPIC ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS ON PROLONGED STAVUDINE THERAPY [J].

LIN, PF ;

SAMANTA, H ;

ROSE, RE ;

PATICK, AK ;

TRIMBLE, J ;

BECHTOLD, CM ;

REVIE, DR ;

KHAN, NC ;

FEDERICI, ME ;

LI, H ;

LEE, A ;

ANDERSON, RE ;

COLONNO, RJ .

JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1157-1164

[8] DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS/MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL [J].

MONTANER, JSG ;

SCHECHTER, MT ;

RACHLIS, A ;

GILL, J ;

BEAULIEU, R ;

TSOUKAS, C ;

RABOUD, J ;

CAMERON, B ;

SALOMON, H ;

DUNKLE, L ;

SMALDONE, L ;

WAINBERG, MA ;

FANNING, M ;

LALONDE, R ;

BERGERON, M ;

SCHLECH, W ;

SALIT, I ;

PHILLIPS, P ;

SPIRA, B ;

CONWAY, B ;

CASSOL, S ;

OSHAUGNESSY, M ;

THORNE, A ;

SINGER, J ;

AUCLAIR, C .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) :561-571

[9] RESISTANCE TO DDI AND SENSITIVITY TO AZT INDUCED BY A MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE [J].

STCLAIR, MH ;

MARTIN, JL ;

TUDORWILLIAMS, G ;

BACH, MC ;

VAVRO, CL ;

KING, DM ;

KELLAM, P ;

KEMP, SD ;

LARDER, BA .

SCIENCE, 1991, 253 (5027) :1557-1559

← 1 →